86 Results for "

P2Y12

" in MedChemExpress (MCE) Product Catalog:
Products (86)

86 Results for "P2Y12" in MCE Product Catalog:

32
32 Publications Verification
Cat. No.: HY-15283
CAS No.: 113665-84-2
Pureté:  99.13%
Synonyms: Clopidogrelum
Target:  

P2Y Receptor

Domaines de recherche:  

Cardiovascular Disease Cancer

Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
loading...
    loading...
32
32 Publications Verification
Cat. No.: HY-17459
CAS No.: 120202-66-6
Synonyms: (S)-(+)-Clopidogrel bisulfate; (S)-(+)-Clopidogrel hydrogen sulfate
Domaines de recherche:  

Cardiovascular Disease Cancer

Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively . Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation .Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-10064
CAS No.: 274693-27-5
Pureté:  99.95%
Synonyms: AZD6140; AR-C 126532XX
Target:  

P2Y Receptor

Domaines de recherche:  

Cardiovascular Disease Cancer

Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-19638A
CAS No.: 163706-36-3
Synonyms: AR-C69931MX tetrasodium
Target:  

P2Y Receptor

Domaines de recherche:  

Cardiovascular Disease Inflammation/Immunology

Cangrelor tetrasodium, an adenosine triphosphate analogue, is a reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor tetrasodium directly blocks adenosine diphosphate (ADP)-induced activation and aggregation of platelets. Cangrelor tetrasodium is also a nonspecific GPR17 antagonist .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-110322
CAS No.: 1992047-65-0
Pureté:  99.89%
Target:  

P2Y Receptor

Domaines de recherche:  

Inflammation/Immunology

PPTN hydrochloride is a potent, high-affinity, competitive and highly selective P2Y14 receptor antagonist with a KB value of 434 pM. PPTN hydrochloride exhibits no agonist or antagonist effect at the P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, or P2Y13 receptors. Anti-inflammatory and anti-immune activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-110322A
CAS No.: 1160271-30-6
Pureté:  99.63%
Target:  

P2Y Receptor

Domaines de recherche:  

Inflammation/Immunology

PPTN, a chemical probe, is a potent, high-affinity, competitive and highly selective P2Y14 receptor antagonist with a KB value of 434 pM. PPTN exhibits no agonist or antagonist effect at the P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, or P2Y13 receptors. Anti-inflammatory and immune activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108660
CAS No.: 1052087-90-7
Pureté:  ≥98.0%
Target:  

P2Y Receptor

Domaines de recherche:  

Cardiovascular Disease

PSB-0739 is a high-affinity potent, competitive, nonselective platelet P2Y12 receptor antagonist with a Ki values of 24.9 nM. The P2Y12 receptor plays a crucial role in platelet aggregation. Antithrombotic effect .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15284
CAS No.: 150322-43-3
Pureté:  99.75%
Synonyms: PCR 4099
Target:  

P2Y Receptor

Domaines de recherche:  

Cardiovascular Disease

Prasugrel (PCR 4099), a thienopyridine and proagent, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-118284
CAS No.: 1314081-53-2
Pureté:  98.86%
Target:  

P2Y Receptor

Domaines de recherche:  

Cardiovascular Disease

Vicagrel is a potent, safe and orally active antiplatelet agent, which works by irreversibly inhibiting P2Y12 receptor. Vicagrel can be used for the research of blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15284A
CAS No.: 389574-19-0
Pureté:  98.49%
Synonyms: PCR 4099 hydrochloride
Target:  

P2Y Receptor

Domaines de recherche:  

Cardiovascular Disease

Prasugrel hydrochloride (PCR 4099 hydrochloride), a thienopyridine and proagent, inhibits platelet function. Prasugrel hydrochloride is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125989
CAS No.: 22140-20-1
Pureté:  98.94%
Synonyms: 2-MeSAMP; 2-Methylthioadenosine 5′-monophosphate; 2-Methylthioadenosine 5′-phosphate
Target:  

P2Y Receptor

Domaines de recherche:  

Cardiovascular Disease

2-Methylthio-AMP (2-MeSAMP) is a selective and direct P2Y12 antagonist. 2-Methylthio-AMP is an inhibitor of ADP-dependent platelet aggregation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18775
CAS No.: 110505-75-4
Synonyms: Para-topolin riboside
N6-(4-Hydroxybenzyl) adenosine (Para-topolin riboside) is an equilibrative nucleoside transporter 1 (ENT1) inhibitor and a selective agonist of adenosine A2a receptor (A2aR), and also exhibits activity against P2Y12 receptor. N6-(4-Hydroxybenzyl) adenosine reduces ethanol intake and preference, attenuates operant conditioning-induced ethanol place preference, decreases the value of ethanol-related rewards, and inhibits collagen-induced platelet aggregation. N6-(4-Hydroxybenzyl) adenosine can be used in studies related to alcohol use disorder .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0910
CAS No.: 155683-00-4
Notoginsenoside Ft1 is an orally active bioactive saponin. Notoginsenoside Ft1 inhibits the PI3K/AKT/mTOR signaling pathway, activates the p38 MAPK and ERK1/2 signaling pathways, and increases the proportion of CD8 + T cells, thereby inducing apoptosis and lysosomal cell death in various cancer cells, and promoting angiogenesis. Notoginsenoside Ft1 causes vasodilation by activating glucocorticoid receptors (GR) and estrogen receptor beta (ERβ) in endothelial cells. Notoginsenoside Ft1 increases intracellular Ca 2+ accumulation, reduces cAMP levels by activating a signaling network mediated through P2Y12 receptors, and promotes platelet aggregation, thereby exerting a procoagulant effect. Notoginsenoside Ft1 inhibits ferroptosis (ferroptosis) in renal tubular epithelial cells by activating the TGR5 receptor, thereby demonstrating a renal protective effect. Notoginsenoside Ft1 acts as a TGR5 agonist and an FXR antagonist to combat obesity and insulin resistance .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-149454
CAS No.: 2738381-94-5
Pureté:  99.87%
Target:  

P2Y Receptor

Domaines de recherche:  

Cancer

P2Y1/P2Y12 antagonist-1 (compound 24w) is an orally available dual inhibitor of P2Y1 and P2Y12 with antiplatelet activity. P2Y1/P2Y12 antagonist-1 inhibits ADP-induced platelet aggregation in rabbit plasma with an IC50 of 4.23 μM. P2Y1/P2Y12 antagonist-1 exhibits potent inhibitory effects in rat thrombosis model.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10064S
CAS No.: 1265911-55-4
Ticagrelor-d7 is the deuterium labeled Ticagrelor. Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P83390
Synonyms: HORK3; P2Y12; ADPG-R; BDPLT8; SP1999; P2T(AC); P2Y(AC); P2Y(12)R; P2Y(ADP); P2Y(cyc)

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P87002
Synonyms: ADP glucose receptor antibody; ADP-glucose receptor antibody; ADPG R antibody; ADPG-R antibody; ADPGR antibody; BDPLT8 antibody; G protein coupled receptor SP1999 antibody; Gi coupled ADP receptor HORK 3 antibody; Gi coupled ADP receptor HORK3 antibody; HORK 3 antibody; ADP glucose receptor antibody; ADP-glucose receptor antibody; ADPG R antibody; ADPG-R antibody; ADPGR antibody; BDPLT8 antibody; G protein coupled receptor SP1999 antibody; Gi coupled ADP receptor HORK 3 antibody; Gi coupled ADP receptor HORK3 antibody; HORK 3 antibody; HORK3 antibody; P2RY 12 antibody; P2RY12 antibody; P2T(AC) antibody; P2Y 12 antibody; P2Y purinoceptor 12 antibody; P2Y(12)R antibody; P2Y(AC) antibody; P2Y(ADP) antibody; P2Y(cyc) antibody; P2Y12 antibody; P2Y12 platelet ADP receptor antibody; P2Y12_HUMAN antibody; Platelet ADP receptor antibody; Purinergic receptor P2RY12 antibody; Purinergic receptor P2Y G protein coupled 12 antibody; Purinergic receptor P2Y12 antibody; Putative G protein coupled receptor antibody; SP 1999 antibody; SP1999 antibody;

Host:  

Rat

Application:  

IHC-F, IHC-P

Reactivity:  

Mouse, Rat

loading...
    loading...
Cat. No.: HY-134353B
CAS No.: 73536-95-5
Pureté:  85.30%
Synonyms: Adenosine 5'-β-thiodiphosphate trilithium
ADP-β-S (Adenosine 5'-(β-thiodiphosphate)) trilithium is a non-hydrolyzable ADP analog and a P2Y12 receptor agonist. ADP-β-S trilithium activates the P2Y12 receptor in microglia, thereby triggering downstream inflammatory signaling pathways. ADP-β-S trilithium activates P2Y purinergic receptors in rat pancreatic β cells and enhances glucose-induced insulin secretion. ADP-β-S trilithium can be used in the research of diseases such as inflammation and diabetes .
loading...
    loading...
Cat. No.: HY-15799
CAS No.: 919351-41-0
Pureté:  99.33%
Target:  

P2Y Receptor

Domaines de recherche:  

Cardiovascular Disease

AZD1283 is a potent P2Y12 receptor antagonist with a binding IC50 of 11 nM and a GTPγS IC50 of 25 nM. AZD1283 has excellent antiplatelet aggregation potency. AZD1283 can be used to research thromboembolic disorders .
loading...
    loading...
Cat. No.: HY-108648
CAS No.: 475193-31-8
Pureté:  99.90%
Synonyms: 2-Methylthioadenosine diphosphate trisodium; 2-Methylthio-ADP trisodium
Target:  

P2Y Receptor

Domaines de recherche:  

Neurological Disease

2-Methylthioadenosine diphosphate trisodium is a potent purinergic P2Y receptors agonist, with EC50s of 19, 6.2, and 5 nM for human P2Y13, mouse P2Y13 and human P2Y12, respectively. 2-Methylthioadenosine diphosphate trisodium has pEC50s of 8.29 and 5.75 for human P2Y1 and rat P2Y6, respectively. 2-Methylthioadenosine diphosphate trisodium induces platelet aggregation and shape change, and inhibits cyclic AMP accumulation in platelets exposed to prostaglandin E1 .
loading...
    loading...